期刊文献+

超敏C反应蛋白、脑钠肽与急性冠脉综合征的相关性研究 被引量:14

High sensitive C-reactive protein,brain natriuretic peptide in acute coronary syndrome
在线阅读 下载PDF
导出
摘要 目的探讨急性冠脉综合征(ACS)患者血中超敏C-反应蛋白(hs-CRP)和脑钠肽(BNP)的含量及它们与急性冠脉综合征(ACS)的相关性。方法选取急性冠脉综合征(ACS)患者100例作为观察组,其中急性心肌梗死(AM I)组患者50例,不稳定型心绞痛(USAP)组患者50例。稳定型心绞痛(SAP)组患者30例,20例健康者作为对照组,采用乳胶增强免疫比浊法测定研究对象血清hs-CRP的浓度,用酶联免疫吸附法(ELISA)测定血浆BNP浓度。结果血中hs-CRP、BNP水平ACS组、SAP组显著高于对照组(P<0.05),ACS组显著高于SAP组(P<0.05),AM I组显著高于USAP组(P<0.05),且hs-CRP和BNP呈正相关。结论ACS患者血中hs-CRP、BNP浓度与冠心病危险程度存在明显的相关性,可以作为判断冠脉病变严重程度的重要指标。 Aim To detect the levels of plasma high sensitive C-reactive protein, brain natriuretic peptide (BNP) and the correlation of the patients with acute coronary syndrome(ACS). Methods 100 patients with ACS were divided into acute myocardial infarction(AMI) group ( n = 50 ), USAP group ( n = 50 ), stable angina pectoris (SAP) group ( n = 30 ), and healthy control group ( n = 20 ) subjects matched for age,sex . The levels of plasma hs-CRP were measured with immune nephelometry. BNP were measured with enzyme-linked immunosorbent assay. Results The levels of hs-CRP, BNP in patients with ACS and SAP were significantly higher than those in control group (P 〈 0.05 ). The levels of hs-CRP, BNP in ACS group were significantly higher than those in SAP group ( P 〈 0.05 ). There was significant difference between the AMI and USAP groups ( P 〈 0.05 ). The correlation between hs-CRP and BNP level was positive in ACS. Conclusion There is a significant correlation between hs-CRP, BNP and the risk level of coronary heart disease. These two indexs can evaluate the severity degree.
出处 《安徽医药》 CAS 2010年第8期914-915,共2页 Anhui Medical and Pharmaceutical Journal
关键词 超敏C-反应蛋白 脑钠肽 急性冠脉综合征 high sensitive C-reactive protein brain natriuretic peptide acute coronary syndrome
  • 相关文献

参考文献16

  • 1LI JJ,Fang CH.C-reactive protein is not only an inflammtory marker but also a direct cause of cardiovascular disease[J].Med Hypotheses,2004,62:499-506.
  • 2Yeh ET,Willerson JT.Coming of age of C-reactive protein:using inflammation markers in cardiology[J].Circulation,2003,107(3):370-2.
  • 3Matsushita K,Yatsuya H,Tamakoshi K,et al.High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk[J].Circ J,2007,71(6):820-5.
  • 4Sander K,Horn CS,Briesenick C,et al.High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men:the INVADE Study[J].Stroke,2007,38(11):2881-6.
  • 5Morrow DA,De Lemons JA,Sabatine MS,et al.Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/ non-ST elevation myocardial infarction[J].J Am Coll Cardiol,2003,41 (8):1264-72.
  • 6Morrow DA,De Lemos JA,Sabatine MS,et al.Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation myocardial infarction:B-type natriuretic peptide and prognosis in TACTICS-TIMI18[J].J Am Coll Cardiol,2003,41:1264-72.
  • 7Christopher H,Christian W,Veselin M,et al.N-terminal pro-B-type natriuretic peptide,levels for dynamic risk stratification of patients with acute coronary syndromes[J].Circulation,2004,110:3206-12.
  • 8Galvani M,Ottani F,Oltrona L,et al.N-Terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes[J].Circulation,2004,110:128-34.
  • 9Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction summary article:a report of the American College of Cardiology/American Heart Association task force on practice guidelines[J].Am Coll Cardiol,2002,40(7):1366-74.
  • 10Declos TW.Function of C-reactive protein[J].Ann Med,2000,32(3):274-8.

二级参考文献45

  • 1US Departmentof Healthand Human Services Monograph,1996年,30页
  • 2Hatanaka K,Pathol Int,1995年,45卷,631页
  • 3Liuzzo G,New Engl J Med,1994年,331卷,417页
  • 4Cheung BMY, Kumana CR. Nariuretic peptides-relevance in cardiac disease. JAMA, 1998,280:1983-1984.
  • 5Etsuo M, Hirofumi Y, Michihiro Y, et al. Increased plamsma levels of brain natriuritic peptide in patients with acute myocardial infarction. Circulation, 1993,88:82-91.
  • 6Dicstein K. Natriuretic peptides in detection of heart failure. Lancet, 1998,35: 3-4.
  • 7Clerico A, Iervasi G, Chicca M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 1998,21: 170-179.
  • 8Maisel A. B-type natriuretic levels: a potential novel "White count" for congestive heart failure. J Cardiac Fail, 2001, 7: 183-193.
  • 9Brandt RR, Burnett Jr. Humoral control of the kidney during congestive heart failure: role of cardiac natriuretic peptides and angiotensin II. In: Poole-Wilson PA, Colucci WS, Massie BM, eds. Heart Failure. New York: Churchill Livingstone, 1997.143-154.
  • 10Mair J, Hammerer-lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med, 2001, 39:571-588.

共引文献517

同被引文献109

引证文献14

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部